Cart - MedWorks Media

You Have 12 Items In Your Cart

Product	Price	Quantity	Subtotal	Remove
Marcia L. Verduin, MD: Psychosis and Delirium Following Metabolife Use	$30.00	1	$30.00	×
Ahmad Ghanizadeh - Does Risperidone Improve Hyperacusia in Children with Autism?	$30.00	1	$30.00	×
Aysegul Yolga Tahiroglu, MD: Polypharmacy and EPS in a Child; A Case Report	$30.00	1	$30.00	×
A Phase 2 Open Label Study of Efficacy, Safety, and Tolerability of SLS-002 (Intranasal Racemic Ketamine) in Adults with MDD at Imminent Risk of Suicide	$30.00	A Phase 2 Open Label Study of Efficacy, Safety, and Tolerability of SLS-002 (Intranasal Racemic Ketamine) in Adults with MDD at Imminent Risk of Suicide quantity	$30.00	×
Agomelatine Monotherapy for Autism—A Case Report	$30.00	Agomelatine Monotherapy for Autism—A Case Report quantity	$30.00	×
Managing Deep Vein Thrombosis Risk in Oncology Patients Office and Outpatient Settings	$10.00	1	$10.00	×
Demographic and Clinical Characteristics of Antipsychotic Drug-Treated Older Adults with Bipolar Disorder from the Global Aging & Geriatric Experiments in Bipolar Disorder Database (GAGE –BD)	$30.00	Demographic and Clinical Characteristics of Antipsychotic Drug-Treated Older Adults with Bipolar Disorder from the Global Aging & Geriatric Experiments in Bipolar Disorder Database (GAGE –BD) quantity	$30.00	×
Use of Colony-Stimulating Factors in the Elderly Cancer Patient	$0.00	1	$0.00	×
Carol Vidal Castro, MD - Reboxetine: An Alternative for Induced Bruxism	$30.00	1	$30.00	×
Thrombolytic Therapy in Cocaine Users with Ischemic Stroke: A Review of Current Practice	$30.00	Thrombolytic Therapy in Cocaine Users with Ischemic Stroke: A Review of Current Practice quantity	$30.00	×
Ziprasidone Induced Tardive Cervical Dystonia	$30.00	1	$30.00	×
Adjunctive Pimavanserin in Patients with Major Depressive Disorder: Combined Results from Two Randomized, Double-Blind, Placebo-Controlled Phase 3 Studies	$30.00	Adjunctive Pimavanserin in Patients with Major Depressive Disorder: Combined Results from Two Randomized, Double-Blind, Placebo-Controlled Phase 3 Studies quantity	$30.00	×